Clinical Trials Browser

Phase 1/2 × Decitabine × Tumor-Agnostic × Clear all

NCT02499861 2017-11-17

Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies

Phase 1/2 Completed

Neoplasms